Standard InChI: InChI=1S/C35H39N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,16,18,20,23,27-29,36,44H,8,13-15,17,19H2,1-3H3,(H,37,41)/t23-,27-,28+,29+,34-,35+/m1/s1
1.Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P.. (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)., 51 (11):[PMID:18457386][10.1021/jm7015683]
2.Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5):[PMID:17417631][10.1038/nchembio873]
3.PubChem BioAssay data set,
4.Yasuda K, Lan LB, Sanglard D, Furuya K, Schuetz JD, Schuetz EG.. (2002) Interaction of cytochrome P450 3A inhibitors with P-glycoprotein., 303 (1):[PMID:12235267][10.1124/jpet.102.037549]
5.Ekins S, Kim RB, Leake BF, Dantzig AH, Schuetz EG, Lan LB, Yasuda K, Shepard RL, Winter MA, Schuetz JD, Wikel JH, Wrighton SA.. (2002) Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein., 61 (1):[PMID:11961113][10.1124/mol.61.5.964]